Rosa Morros

1.6k total citations
80 papers, 973 citations indexed

About

Rosa Morros is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rosa Morros has authored 80 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 19 papers in Cardiology and Cardiovascular Medicine and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rosa Morros's work include Atrial Fibrillation Management and Outcomes (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Pneumonia and Respiratory Infections (8 papers). Rosa Morros is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Pneumonia and Respiratory Infections (8 papers). Rosa Morros collaborates with scholars based in Spain, United States and Denmark. Rosa Morros's co-authors include Bonaventura Bolíbar, Maria Giner‐Soriano, Magdalena Rosell, Eduard Hermosilla, Daniel Prieto‐Alhambra, Manel Mata‐Cases, Josep Franch‐Nadal, Manuel Medina, Irene Vinagre and Francesc Fina and has published in prestigious journals such as PLoS ONE, Diabetes Care and Scientific Reports.

In The Last Decade

Rosa Morros

72 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Morros Spain 15 212 209 166 108 100 80 973
Stefania Spila Alegiani Italy 17 202 1.0× 240 1.1× 142 0.9× 82 0.8× 121 1.2× 58 969
Amit D. Raval United States 21 332 1.6× 363 1.7× 156 0.9× 125 1.2× 169 1.7× 80 1.3k
Carrie McAdam‐Marx United States 20 305 1.4× 290 1.4× 115 0.7× 93 0.9× 137 1.4× 74 1.1k
O E Ayodele Nigeria 21 199 0.9× 183 0.9× 276 1.7× 65 0.6× 97 1.0× 59 1.3k
Huang‐Tz Ou Taiwan 22 555 2.6× 199 1.0× 142 0.9× 172 1.6× 141 1.4× 112 1.3k
Jian Ying United States 18 195 0.9× 120 0.6× 115 0.7× 125 1.2× 244 2.4× 55 1.1k
Joanne LaFleur United States 18 307 1.4× 193 0.9× 148 0.9× 171 1.6× 200 2.0× 58 1.4k
Elisa Martín‐Merino Spain 19 118 0.6× 169 0.8× 265 1.6× 49 0.5× 182 1.8× 72 1.2k
William Hinton United Kingdom 18 365 1.7× 177 0.8× 110 0.7× 131 1.2× 177 1.8× 61 1.1k
Scott Martin Vouri United States 16 105 0.5× 179 0.9× 117 0.7× 51 0.5× 97 1.0× 87 977

Countries citing papers authored by Rosa Morros

Since Specialization
Citations

This map shows the geographic impact of Rosa Morros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Morros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Morros more than expected).

Fields of papers citing papers by Rosa Morros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Morros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Morros. The network helps show where Rosa Morros may publish in the future.

Co-authorship network of co-authors of Rosa Morros

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Morros. A scholar is included among the top collaborators of Rosa Morros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Morros. Rosa Morros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gómez-Lumbreras, Ainhoa, et al.. (2024). Drug Exposure During Pregnancy: A Case-Control Study from a Primary Care Database. Women s Health Reports. 5(1). 13–21. 2 indexed citations
3.
Pérez‐Sáez, María José, et al.. (2024). NSAIDs, analgesics, antiplatelet drugs, and decline in renal function: a retrospective case-control study with SIDIAP database. BMC Pharmacology and Toxicology. 25(1). 58–58. 1 indexed citations
4.
Ouchi, Dan, et al.. (2023). Longitudinal treatment patterns in patients recently diagnosed with type 2 diabetes mellitus in Catalonia. Diabetes Research and Clinical Practice. 202. 110777–110777. 2 indexed citations
5.
Giner‐Soriano, Maria, et al.. (2023). Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review. Biomedicines. 11(4). 1206–1206. 14 indexed citations
6.
Ouchi, Dan, et al.. (2023). Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study. Drugs - Real World Outcomes. 10(3). 447–457. 1 indexed citations
7.
Gómez-Lumbreras, Ainhoa, et al.. (2023). Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain. BMJ Open. 13(8). e071335–e071335. 6 indexed citations
8.
Llor, Carl, Ana Moragas, Dan Ouchi, et al.. (2022). Effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with uncomplicated acute bronchitis: a multiarm randomized clinical trial. Family Practice. 40(2). 407–413. 6 indexed citations
9.
Ouchi, Dan, et al.. (2022). Automatic Estimation of the Most Likely Drug Combination in Electronic Health Records Using the Smooth Algorithm: Development and Validation Study. JMIR Medical Informatics. 10(11). e37976–e37976. 3 indexed citations
10.
Giner‐Soriano, Maria, et al.. (2022). Outcomes of COVID-19 Infection in People Previously Vaccinated Against Influenza: Population-Based Cohort Study Using Primary Health Care Electronic Records. JMIR Public Health and Surveillance. 8(11). e36712–e36712. 6 indexed citations
11.
14.
Forns, Joan, Anton Pottegård, Beatriz Poblador‐Plou, et al.. (2019). Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators. Journal of Affective Disorders. 249. 242–252. 47 indexed citations
15.
Forns, Joan, Miguel Cainzos‐Achirica, Maja Hellfritzsch, et al.. (2019). Validity of ICD‐9 and ICD‐10 codes used to identify acute liver injury: A study in three European data sources. Pharmacoepidemiology and Drug Safety. 28(7). 965–975. 20 indexed citations
16.
Giner‐Soriano, Maria, et al.. (2018). Impact of Medication Adherence on Mortality and Cardiovascular Morbidity: Protocol for a Population-Based Cohort Study. JMIR Research Protocols. 7(3). e73–e73. 7 indexed citations
18.
Casajuana‐Closas, Marc, et al.. (2018). Annual costs attributed to atrial fibrillation management: cross-sectional study of primary healthcare electronic records. The European Journal of Health Economics. 19(8). 1129–1136. 5 indexed citations
20.
Prieto‐Alhambra, Daniel, Rosa Morros, & N K Arden. (2013). ASSOCIATION BETWEEN CHONDROITIN SULPHATE USE AND THE RISK OF TOTAL KNEE ARTRHOPLASTY IN OSTEOARTHITIS PATIENTS: A PROPENSITY-SCORE MATCHED COHORT STUDY. Basic & Clinical Pharmacology & Toxicology. 113. 34–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026